Skip to main content
Top
Published in: Endocrine 3/2014

01-12-2014 | Original Article

Assessment of early renal damage in diabetic rhesus monkeys

Authors: Dan Wang, Jingping Liu, Sirong He, Chengshi Wang, Younan Chen, Lichaun Yang, Fang Liu, Yan Ren, Haoming Tian, Guang Yang, Guangneng Liao, Lan Li, Meimei Shi, Yujia Yuan, Jiuming Zhao, Jingqiu Cheng, Yanrong Lu

Published in: Endocrine | Issue 3/2014

Login to get access

Abstract

The objectives of the study were to improve the model system of diabetic nephropathy in nonhuman primates and assess the early renal damage. Diabetes was induced in monkeys by streptozotocin, and the animals were administered exogenous insulin to control blood glucose (BG). Animals were divided into four groups, including the normal group (N = 3), group A (streptozotocin diabetic model with control of BG < 10 mmol/L, N = 3), group B (streptozotocin diabetic model with control of BG between 15 and 20 mmol/L, N = 4), and group C (streptozotocin diabetic model with control of BG between 15 and 20 mmol/L and high-sodium and high-fat diet, N = 4). The following parameters were evaluated: (1) blood biochemistry and routine urinalysis, (2) color Doppler ultrasound, (3) angiography, (4) renal biopsy, and (5) renal fibrosis-related gene expression levels. Animals in group C developed progressive histologic changes with typical diabetic nephropathy resembling diabetic nephropathy in human patients and exhibited accelerated development of diabetic nephropathy compared with other nonhuman primate models. Significant changes in the expression of the Smad2/3 gene and eNOS in renal tissue were also observed in the early stage of diabetic nephropathy. In conclusion, our model is an excellent model of diabetic nephropathy for understanding the pathogenesis of diabetic nephropathy.
Appendix
Available only for authorised users
Literature
1.
go back to reference S. Dronavalli, I. Duka, G.L. Bakris, The pathogenesis of diabetic nephropathy. Nat. Clin. Pract. Endocrinol. Metab. 4(8), 444–452 (2008)PubMedCrossRef S. Dronavalli, I. Duka, G.L. Bakris, The pathogenesis of diabetic nephropathy. Nat. Clin. Pract. Endocrinol. Metab. 4(8), 444–452 (2008)PubMedCrossRef
2.
go back to reference C.F. Howard Jr, Nonhuman primates as models for the study of human diabetes mellitus. Diabetes 31(Suppl 1 Pt 2), 37–42 (1982)PubMedCrossRef C.F. Howard Jr, Nonhuman primates as models for the study of human diabetes mellitus. Diabetes 31(Suppl 1 Pt 2), 37–42 (1982)PubMedCrossRef
3.
go back to reference S.E. Thomson, S.V. McLennan, P.D. Kirwan, S.J. Heffernan, A. Hennessy, D.K. Yue, S.M. Twigg, Renal connective tissue growth factor correlates with glomerular basement membrane thickness and prospective albuminuria in a non-human primate model of diabetes: possible predictive marker for incipient diabetic nephropathy. J. Diabetes Complic. 22(4), 284–294 (2008)CrossRef S.E. Thomson, S.V. McLennan, P.D. Kirwan, S.J. Heffernan, A. Hennessy, D.K. Yue, S.M. Twigg, Renal connective tissue growth factor correlates with glomerular basement membrane thickness and prospective albuminuria in a non-human primate model of diabetes: possible predictive marker for incipient diabetic nephropathy. J. Diabetes Complic. 22(4), 284–294 (2008)CrossRef
4.
go back to reference M.C. Thomas, J. Moran, C. Forsblom, V. Harjutsalo, L. Thorn, A. Ahola, J. Wadén, N. Tolonen, M. Saraheimo, D. Gordin, P.H. Groop, FinnDiane Study Group, The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care 34(4), 861–866 (2011)PubMedCentralPubMedCrossRef M.C. Thomas, J. Moran, C. Forsblom, V. Harjutsalo, L. Thorn, A. Ahola, J. Wadén, N. Tolonen, M. Saraheimo, D. Gordin, P.H. Groop, FinnDiane Study Group, The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care 34(4), 861–866 (2011)PubMedCentralPubMedCrossRef
5.
go back to reference J.M. Luther, Sodium intake, ACE inhibition, and progression to ESRD. J. Am. Soc. Nephrol. 23(1), 10–12 (2012)PubMedCrossRef J.M. Luther, Sodium intake, ACE inhibition, and progression to ESRD. J. Am. Soc. Nephrol. 23(1), 10–12 (2012)PubMedCrossRef
6.
go back to reference A.D. Dobrian, S.D. Schriver, T. Lynch, R.L. Prewitt, Effect of salt on hypertension and oxidative stress in a rat model of diet-induced obesity. Am. J. Physiol. Renal. Physiol. 285(4), F619–F628 (2003). Epub 2003 Jun 10PubMed A.D. Dobrian, S.D. Schriver, T. Lynch, R.L. Prewitt, Effect of salt on hypertension and oxidative stress in a rat model of diet-induced obesity. Am. J. Physiol. Renal. Physiol. 285(4), F619–F628 (2003). Epub 2003 Jun 10PubMed
7.
go back to reference K. Alexandraki, C. Piperi, C. Kalofoutis, J. Singh, A. Alaveras, A. Kalofoutis, Inflammatory process in type 2 diabetes: The role of cytokines. Ann. N. Y. Acad. Sci. 1084, 89–117 (2006)PubMedCrossRef K. Alexandraki, C. Piperi, C. Kalofoutis, J. Singh, A. Alaveras, A. Kalofoutis, Inflammatory process in type 2 diabetes: The role of cytokines. Ann. N. Y. Acad. Sci. 1084, 89–117 (2006)PubMedCrossRef
8.
go back to reference K. Kalantarinia, A.S. Awad, H.M. Siragy, Urinary and renal interstitial concentrations of TNF-alpha increase prior to the rise in albuminuria in diabetic rats. Kidiabetic Nephrop. Int. 64(4), 1208–1213 (2003) K. Kalantarinia, A.S. Awad, H.M. Siragy, Urinary and renal interstitial concentrations of TNF-alpha increase prior to the rise in albuminuria in diabetic rats. Kidiabetic Nephrop. Int. 64(4), 1208–1213 (2003)
9.
go back to reference A. Nakamura, K. Shikata, M. Hiramatsu, T. Nakatou, T. Kitamura, J. Wada, T. Itoshima, H. Makino, Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes. Diabetes Care 28(12), 2890–2895 (2005)PubMedCrossRef A. Nakamura, K. Shikata, M. Hiramatsu, T. Nakatou, T. Kitamura, J. Wada, T. Itoshima, H. Makino, Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes. Diabetes Care 28(12), 2890–2895 (2005)PubMedCrossRef
10.
go back to reference G.H. Tesch, MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy. Am. J. Physiol. Renal. Physiol. 294(4), F697–F701 (2008)PubMedCrossRef G.H. Tesch, MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy. Am. J. Physiol. Renal. Physiol. 294(4), F697–F701 (2008)PubMedCrossRef
11.
12.
go back to reference T. Nakagawa, W. Sato, O. Glushakova, M. Heinig, T. Clarke, M. Campbell-Thompson, Y. Yuzawa, M.A. Atkinson, R.J. Johnson, B. Croker, Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. J. Am. Soc. Nephrol. 18(2), 539–550 (2007). Epub 2007 Jan 3PubMedCrossRef T. Nakagawa, W. Sato, O. Glushakova, M. Heinig, T. Clarke, M. Campbell-Thompson, Y. Yuzawa, M.A. Atkinson, R.J. Johnson, B. Croker, Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. J. Am. Soc. Nephrol. 18(2), 539–550 (2007). Epub 2007 Jan 3PubMedCrossRef
13.
go back to reference M. Tong, Y. Wang, Y. Wang, H. Chen, C. Wang, L. Yang, J. Axelsson, B. Lindholm, Genistein attenuates advanced glycation end product-induced expression of fibronectin and connective tissue growth factor. Am. J. Nephrol. 36(1), 34–40 (2012)PubMedCrossRef M. Tong, Y. Wang, Y. Wang, H. Chen, C. Wang, L. Yang, J. Axelsson, B. Lindholm, Genistein attenuates advanced glycation end product-induced expression of fibronectin and connective tissue growth factor. Am. J. Nephrol. 36(1), 34–40 (2012)PubMedCrossRef
14.
go back to reference I.S. Park, H. Kiyomoto, S.L. Abboud, H.E. Abboud, Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes. Diabetes 46(3), 473–480 (1997)PubMedCrossRef I.S. Park, H. Kiyomoto, S.L. Abboud, H.E. Abboud, Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes. Diabetes 46(3), 473–480 (1997)PubMedCrossRef
15.
go back to reference M. Sato, Y. Muragaki, S. Saika, A.B. Roberts, A. Ooshima, Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J. Clin. Invest. 112(10), 1486–1494 (2003)PubMedCentralPubMedCrossRef M. Sato, Y. Muragaki, S. Saika, A.B. Roberts, A. Ooshima, Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J. Clin. Invest. 112(10), 1486–1494 (2003)PubMedCentralPubMedCrossRef
16.
go back to reference X. Jin, L. Zeng, S. He, Y. Chen, B. Tian, G. Mai, G. Yang, L. Wei, Y. Zhang, H. Li, L. Wang, C. Qiao, J. Cheng, Y. Lu, Comparison of single high-dose streptozotocin with partial pancreatectomy combined with low-dose streptozotocin for diabetes induction in rhesus monkeys. Exp. Biol. Med. (Maywood). 235(7), 877–885 (2010)PubMedCrossRef X. Jin, L. Zeng, S. He, Y. Chen, B. Tian, G. Mai, G. Yang, L. Wei, Y. Zhang, H. Li, L. Wang, C. Qiao, J. Cheng, Y. Lu, Comparison of single high-dose streptozotocin with partial pancreatectomy combined with low-dose streptozotocin for diabetes induction in rhesus monkeys. Exp. Biol. Med. (Maywood). 235(7), 877–885 (2010)PubMedCrossRef
17.
go back to reference H. Sugimoto, V.S. LeBleu, D. Bosukonda, P. Keck, G. Taduri, W. Bechtel, H. Okada, W. Carlson Jr, P. Bey, M. Rusckowski, B. Tampe, D. Tampe, K. Kanasaki, M. Zeisberg, R. Kalluri, Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis. Nat. Med. 18(3), 396–404 (2012)PubMedCentralPubMedCrossRef H. Sugimoto, V.S. LeBleu, D. Bosukonda, P. Keck, G. Taduri, W. Bechtel, H. Okada, W. Carlson Jr, P. Bey, M. Rusckowski, B. Tampe, D. Tampe, K. Kanasaki, M. Zeisberg, R. Kalluri, Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis. Nat. Med. 18(3), 396–404 (2012)PubMedCentralPubMedCrossRef
18.
go back to reference Y. Ohkubo, H. Kishikawa, E. Araki, T. Miyata, S. Isami, S. Motoyoshi, Y. Kojima, N. Furuyoshi, M. Shichiri, Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res. Clin. Pract. 28(2), 103–117 (1995)PubMedCrossRef Y. Ohkubo, H. Kishikawa, E. Araki, T. Miyata, S. Isami, S. Motoyoshi, Y. Kojima, N. Furuyoshi, M. Shichiri, Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res. Clin. Pract. 28(2), 103–117 (1995)PubMedCrossRef
19.
go back to reference P.H. Wang, J. Lau, T.C. Chalmers, Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes. Lancet 341(8856), 1306–1309 (1993)PubMedCrossRef P.H. Wang, J. Lau, T.C. Chalmers, Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes. Lancet 341(8856), 1306–1309 (1993)PubMedCrossRef
20.
go back to reference Writing Team for the Diabetes Control and Complications Trial/Epidemiology of diabetes Interventions and Complications Research Group, Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 287(19), 2563–2569 (2002)CrossRef Writing Team for the Diabetes Control and Complications Trial/Epidemiology of diabetes Interventions and Complications Research Group, Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 287(19), 2563–2569 (2002)CrossRef
21.
go back to reference I. Ranjit Unnikrishnan, R.M. Anjana, V. Mohan, Importance of controlling diabetes early–the concept of metabolic memory, legacy effect and the case for early insulinisation. J. Assoc. Physicians India 59, 8–12 (2011)PubMed I. Ranjit Unnikrishnan, R.M. Anjana, V. Mohan, Importance of controlling diabetes early–the concept of metabolic memory, legacy effect and the case for early insulinisation. J. Assoc. Physicians India 59, 8–12 (2011)PubMed
22.
go back to reference T.W. Tervaert, A.L. Mooyaart, K. Amann, A.H. Cohen, H.T. Cook, C.B. Drachenberg, F. Ferrario, A.B. Fogo, M. Haas, E. de Heer, K. Joh, L.H. Noël, J. Radhakrishnan, S.V. Seshan, I.M. Bajema, J.A. Bruijn, Renal Pathology Society, Pathologic classification of diabetic nephropathy. J. Am. Soc. Nephrol. 21(4), 556–563 (2010)PubMedCrossRef T.W. Tervaert, A.L. Mooyaart, K. Amann, A.H. Cohen, H.T. Cook, C.B. Drachenberg, F. Ferrario, A.B. Fogo, M. Haas, E. de Heer, K. Joh, L.H. Noël, J. Radhakrishnan, S.V. Seshan, I.M. Bajema, J.A. Bruijn, Renal Pathology Society, Pathologic classification of diabetic nephropathy. J. Am. Soc. Nephrol. 21(4), 556–563 (2010)PubMedCrossRef
23.
go back to reference P.P. Rood, R. Bottino, A.N. Balamurugan, C. Smetanka, M. Ezzelarab, J. Busch, H. Hara, M. Trucco, D.K. Cooper, Induction of diabetes in cynomolgus monkeys with high-dose streptozotocin: adverse effects and early responses. Pancreas 33(3), 287–292 (2006)PubMedCrossRef P.P. Rood, R. Bottino, A.N. Balamurugan, C. Smetanka, M. Ezzelarab, J. Busch, H. Hara, M. Trucco, D.K. Cooper, Induction of diabetes in cynomolgus monkeys with high-dose streptozotocin: adverse effects and early responses. Pancreas 33(3), 287–292 (2006)PubMedCrossRef
24.
go back to reference L.M. Russo, R.M. Sandoval, S.B. Campos, B.A. Molitoris, W.D. Comper, D. Brown, Impaired tubular uptake explains albuminuria in early diabetic nephropathy. J. Am. Soc. Nephrol. 20(3), 489–494 (2009)PubMedCentralPubMedCrossRef L.M. Russo, R.M. Sandoval, S.B. Campos, B.A. Molitoris, W.D. Comper, D. Brown, Impaired tubular uptake explains albuminuria in early diabetic nephropathy. J. Am. Soc. Nephrol. 20(3), 489–494 (2009)PubMedCentralPubMedCrossRef
25.
go back to reference S. He, Y. Chen, L. Wei, X. Jin, L. Zeng, Y. Ren, J. Zhang, L. Wang, H. Li, Y. Lu, J. Cheng, Treatment and risk factor analysis of hypoglycemia in diabetic rhesus monkeys. Exp. Biol. Med. (Maywood). 236(2), 212–218 (2011)PubMedCrossRef S. He, Y. Chen, L. Wei, X. Jin, L. Zeng, Y. Ren, J. Zhang, L. Wang, H. Li, Y. Lu, J. Cheng, Treatment and risk factor analysis of hypoglycemia in diabetic rhesus monkeys. Exp. Biol. Med. (Maywood). 236(2), 212–218 (2011)PubMedCrossRef
26.
go back to reference S. Ferber, A. Halkin, H. Cohen, I. Ber, Y. Einav, I. Goldberg, I. Barshack, R. Seijffers, J. Kopolovic, N. Kaiser, A. Karasik, Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat. Med. 6(5), 568–572 (2000)PubMedCrossRef S. Ferber, A. Halkin, H. Cohen, I. Ber, Y. Einav, I. Goldberg, I. Barshack, R. Seijffers, J. Kopolovic, N. Kaiser, A. Karasik, Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat. Med. 6(5), 568–572 (2000)PubMedCrossRef
27.
go back to reference B. Soria, E. Roche, G. Berná, T. León-Quinto, J.A. Reig, F. Martín, Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 49(2), 157–162 (2000)PubMedCrossRef B. Soria, E. Roche, G. Berná, T. León-Quinto, J.A. Reig, F. Martín, Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 49(2), 157–162 (2000)PubMedCrossRef
28.
go back to reference J. Menne, N. Shushakova, J. Bartels, Y. Kiyan, R. Laudeley, H. Haller, J.K. Park, M. Meier, Dual inhibition of classical protein kinase C-α and protein kinase C-β isoforms protects against experimental murine diabetic nephropathy. Diabetes 62(4), 1167–1174 (2013)PubMedCentralPubMedCrossRef J. Menne, N. Shushakova, J. Bartels, Y. Kiyan, R. Laudeley, H. Haller, J.K. Park, M. Meier, Dual inhibition of classical protein kinase C-α and protein kinase C-β isoforms protects against experimental murine diabetic nephropathy. Diabetes 62(4), 1167–1174 (2013)PubMedCentralPubMedCrossRef
29.
go back to reference N.F. Banki, A. Ver, L.J. Wagner, A. Vannay, P. Degrell, A. Prokai, R. Gellai, L. Lenart, D.N. Szakal, E. Kenesei, K. Rosta, G. Reusz, A.J. Szabo, T. Tulassay, C. Baylis, A. Fekete, Aldosterone antagonists in monotherapy are protective against streptozotocin-induced diabetic nephropathy in rats. PLoS ONE 7(6), e39938 (2012)PubMedCentralPubMedCrossRef N.F. Banki, A. Ver, L.J. Wagner, A. Vannay, P. Degrell, A. Prokai, R. Gellai, L. Lenart, D.N. Szakal, E. Kenesei, K. Rosta, G. Reusz, A.J. Szabo, T. Tulassay, C. Baylis, A. Fekete, Aldosterone antagonists in monotherapy are protective against streptozotocin-induced diabetic nephropathy in rats. PLoS ONE 7(6), e39938 (2012)PubMedCentralPubMedCrossRef
31.
go back to reference P. Boor, K. Sebeková, T. Ostendorf, J. Floege, Treatment targets in renal fibrosis. Nephrol. Dial. Transplant. 22(12), 3391–3407 (2007). Epub 2007 Sep 21PubMedCrossRef P. Boor, K. Sebeková, T. Ostendorf, J. Floege, Treatment targets in renal fibrosis. Nephrol. Dial. Transplant. 22(12), 3391–3407 (2007). Epub 2007 Sep 21PubMedCrossRef
32.
go back to reference D.M. Maahs, G.L. Kinney, P. Wadwa, J.K. Snell-Bergeon, D. Dabelea, J. Hokanson, J. Ehrlich, S. Garg, R.H. Eckel, M.J. Rewers, Hypertension prevalence, awareness, treatment, and control in an adult type 1 diabetes population and a comparable general population. Diabetes Care 28(2), 301–306 (2005)PubMedCrossRef D.M. Maahs, G.L. Kinney, P. Wadwa, J.K. Snell-Bergeon, D. Dabelea, J. Hokanson, J. Ehrlich, S. Garg, R.H. Eckel, M.J. Rewers, Hypertension prevalence, awareness, treatment, and control in an adult type 1 diabetes population and a comparable general population. Diabetes Care 28(2), 301–306 (2005)PubMedCrossRef
33.
go back to reference Michael Shlipak, Associate Professor of Medicine. Diabetic nephropathy. Clin Evid (Online). 2009; 2009: 0606 Michael Shlipak, Associate Professor of Medicine. Diabetic nephropathy. Clin Evid (Online). 2009; 2009: 0606
34.
go back to reference S. Andersen, L. Tarnow, P. Rossing, B.V. Hansen, H.H. Parving, Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy. Kidney Int. 57(2), 601–606 (2000)PubMedCrossRef S. Andersen, L. Tarnow, P. Rossing, B.V. Hansen, H.H. Parving, Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy. Kidney Int. 57(2), 601–606 (2000)PubMedCrossRef
Metadata
Title
Assessment of early renal damage in diabetic rhesus monkeys
Authors
Dan Wang
Jingping Liu
Sirong He
Chengshi Wang
Younan Chen
Lichaun Yang
Fang Liu
Yan Ren
Haoming Tian
Guang Yang
Guangneng Liao
Lan Li
Meimei Shi
Yujia Yuan
Jiuming Zhao
Jingqiu Cheng
Yanrong Lu
Publication date
01-12-2014
Publisher
Springer US
Published in
Endocrine / Issue 3/2014
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-014-0211-4

Other articles of this Issue 3/2014

Endocrine 3/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.